<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882578/bin/fonc-12-802074-g002.jpg"/> </div> <div class="text-side"> <h1>Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN.</h1> <p>
(A–C) Biopsy pathology confirmed mismatch repair (MMR)-deficient leiomyosarcoma (LMS) and the expression of programmed cell death protein-1/programmed cell death-ligand 1(PD-1/PD-L1) using different antibodies. The pathological lesion was measured by H&amp;E staining. (D) Strong positive response of alpha-smooth muscle actin (a-SMA). (E–H) Absence of MSH6 staining and positive staining for MLH1, MSH2, and PMS2 indicated MSH6 deficiency. (I) Immunohistochemistry findings for PD-1. (J–L) Immunohistochemistry findings for PD-L1 using BP60001L, 28-8, or SP142.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35237514/" target="_blank">35237514</a></p><p>Type: Premalignant/Malignant, Category: Smooth muscle</p>
</div> </div></div></body></html>